These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1061 related articles for article (PubMed ID: 33793103)

  • 1. [COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2].
    Yatim A; Gilliet M
    Rev Med Suisse; 2021 Mar; 17(732):646-652. PubMed ID: 33793103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic.
    Discepolo V; Catzola A; Pierri L; Mascolo M; Della Casa F; Vastarella M; Smith G; Travaglino A; Punziano A; Nappa P; Staibano S; Bruzzese E; Fabbrocini G; Guarino A; Alessio M
    JAMA Netw Open; 2021 Jun; 4(6):e2111369. PubMed ID: 34110396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID toes: where do we stand with the current evidence?
    Baeck M; Herman A
    Int J Infect Dis; 2021 Jan; 102():53-55. PubMed ID: 33075530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic.
    Massey PR; Jones KM
    Semin Oncol; 2020 Oct; 47(5):330-334. PubMed ID: 32736881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chilblain-like lesions with prominent bullae in a patient with COVID-19.
    Rubin A; Alamgir M; Rubin J; Rao BK
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33139373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chilblains observed during the COVID-19 pandemic cannot be distinguished from classic, cold-related chilblains.
    De Greef A; Choteau M; Herman A; Bouzin C; Marot L; Dachelet C; Lelotte J; Hoton D; Dumoutier L; Baeck M
    Eur J Dermatol; 2022 May; 32(3):377-383. PubMed ID: 36065533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
    Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
    Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric COVID toes and fingers.
    Koschitzky M; Oyola RR; Lee-Wong M; Abittan B; Silverberg N
    Clin Dermatol; 2021; 39(1):84-91. PubMed ID: 33972057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: A systematic review of articles.
    Molaee H; Emadi SN; M Imunya JMN; Davoudi-Monfared E; Mohammed A; Razavi Z
    Dermatol Ther; 2022 Mar; 35(3):e15298. PubMed ID: 34981615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms.
    Cappel MA; Cappel JA; Wetter DA
    Mayo Clin Proc; 2021 Apr; 96(4):989-1005. PubMed ID: 33714595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
    El Hachem M; Diociaiuti A; Concato C; Carsetti R; Carnevale C; Ciofi Degli Atti M; Giovannelli L; Latella E; Porzio O; Rossi S; Stracuzzi A; Zaffina S; Onetti Muda A; Zambruno G; Alaggio R
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2620-2629. PubMed ID: 32474947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between pandemic chilblains and SARS-CoV-2 infection.
    Gehlhausen JR; Little AJ; Ko CJ; Emmenegger M; Lucas C; Wong P; Klein J; Lu P; Mao T; Jaycox J; Wang E; ; Ugwu N; Muenker C; Mekael D; Klein RQ; Patrignelli R; Antaya R; McNiff J; Damsky W; Kamath K; Shon J; Ring AM; Yildirim I; Omer S; Ko AI; Aguzzi A; Iwasaki A
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chilblain-Like Lesions (CLL) Associated With COVID-19 ("COVID Toes"): A Systematic Review.
    Kashetsky N; Mukovozov IM; Bergman J
    J Cutan Med Surg; 2021; 25(6):627-633. PubMed ID: 33849305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein.
    Ko CJ; Harigopal M; Gehlhausen JR; Bosenberg M; McNiff JM; Damsky W
    J Cutan Pathol; 2021 Jan; 48(1):47-52. PubMed ID: 32895985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID toes: Pernio-like lesions.
    Burke KT; McGinnis KS; Petronic-Rosic V
    Clin Dermatol; 2021; 39(3):380-383. PubMed ID: 34517996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Course and outcome of chilblain-like acral lesions during COVID-19 pandemic.
    Blau K; Lehr S; Aschoff R; Al Gburi S; Brück N; Chapsa M; Schnabel A; Abraham S; Jöhrens K; Beissert S; Günther C
    J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):e29-e31. PubMed ID: 36149533
    [No Abstract]   [Full Text] [Related]  

  • 17. Chilblains-like Nonischemic Eruption During the COVID-19 Pandemic-Distinct Features in Adolescents.
    Gorouhi F
    JAMA Netw Open; 2021 Jun; 4(6):e2111676. PubMed ID: 34110397
    [No Abstract]   [Full Text] [Related]  

  • 18. Pandemic chilblains: Are they SARS-CoV-2-related or not?
    De Greef A; Coulie PG; Baeck M
    Clin Immunol; 2022 Apr; 237():108984. PubMed ID: 35338000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2.
    Lesort C; Kanitakis J; Donzier L; Jullien D
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e630-e632. PubMed ID: 34131969
    [No Abstract]   [Full Text] [Related]  

  • 20. Focus on "COVID Toes".
    Hernandez C; Bruckner AL
    JAMA Dermatol; 2020 Sep; 156(9):1003. PubMed ID: 32584385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 54.